250602-89-2

Upstream product

• 25333-24-8 3-benzoylpropionic acid methyl ester 
• 250602-88-1 [4-(methoxymethoxy)benzyloxy]amine 
• 123-08-0 4-hydroxy-benzaldehyde 
• 7212-39-7 (4-methoxymethoxyphenyl)methanol 

Downstream Products

• 250601-87-7 methyl (E)-4-phenyl-4-{4-[(5-phenylisoxazol-3-yl)methoxy]benzyloxyimino}butyrate 
• 694503-62-3 methyl (E)-4-(4-{[5-(tert-butyldiphenylsilyloxymethyl)-2-phenyl-1,3-oxazol-4-yl]methoxy}benzyloxyimino)-4-phenylbutanoate 

Relevant academic research and scientific papers

Studies on non-thiazolidinedione antidiabetic Agents. 2. Novel oxyiminoalkanoic acid derivatives as potent glucose and lipid lowering agents

We previously reported that (Z)-2-{4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl) methoxy]benzyloxyimino}-2-(4-phenoxyphenyl)acetic acid (3) showed potent glucose and lipid lowering effects in genetically obese and diabetic mice, KKA y. This compound a

Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity

This invention provides a novel oxyiminoalkanoic acid derivative which has excellent hypoglycemic and hypolipidemic actions and which is used for the treatment of diabetes mellitus, hyperlipemia, insulin insensitivity, insulin resistance and impaired glucose tolerance.